3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Breast
1
Conditions
Neoplasms
3
Head and Neck Neoplasms
3
Pain
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Cancer Pain
2
Wounds and Injuries
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Recurrent Laryngeal Nerve Injuries
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pleural Effusion, Malignant
1
Pilonidal Sinus
1
Pain, Postoperative
1
Pain, Intractable
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Intracranial Aneurysm
1
Ileus
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Disease Progression
1
Constipation
1
Colonic Neoplasms
1
Breast Neoplasms
1
Agnosia
1
Accessory Nerve Injuries
1
Interventions
Psilocybin
1
Morphine
1
Lidocaine
1
Gels
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Wounds and Injuries
×
Lidocaine
×
Clear all
NCT05800834
2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2
Unknown
106 enrolled